Cryo-Cell International, Inc.
CCEL
Get informed when a big investor buys or sells
+ FollowMarket Cap$27.57M
Close$
$-1.04
128.7% downside
Current Fair Value
128.7% downsideOvervalued by 128.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $27.57 Million |
|---|---|
| Enterprise Value | $45.53 Million |
| Dividend Yield | $0.65 (-) |
| Earnings per Share | $-0.3 |
| Beta | 0.57 |
| Outstanding Shares | 8,055,476 |
Return
| Return on Equity | 13.89% |
|---|---|
| Return on Assets | -4.06% |
| Return on Invested Capital | -3.80% |
Valuation & Multiples
| P/E Ratio | -11.62 |
|---|---|
| PEG | -20.8 |
| Price to Sales | 1.21 |
| Price to Book Ratio | -1.21 |
| Enterprise Value to Revenue | 1.46 |
| Enterprise Value to EBIT | -26.79 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | -1.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 15, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$7.55 M
Average shareholder expectationNext Earnings Call
Expected Date
October 9, 2026
EPS Estimate
$0.03
Average shareholder expectationRevenue Estimate
$7.45 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.43%▼ 3.18% |
|---|---|
| Total Invested | $881,509▼ 53.39% |
| Investors Holding | 2▼ 9.00% |
ESG Score
No data
About Cryo-Cell International, Inc.
94 employees